Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase GI Medical Oncology Chief Elected as NCI Task Force Vice Chair
PHILADELPHIA (March 28, 2016) — Steven J. Cohen, MD, chief of gastrointestinal medical oncology at Fox Chase Cancer Center, has been elected by his peers to serve as Vice Chair of the NCI Pancreas Task Force of the Gastrointestinal Steering Committee (GISC).
“I am honored to be elected to serve as the Vice Chair on the NCI Pancreas Task Force of the GISC,” said Cohen. “With this position, I will be in a position to help set and support the current national clinical trial landscape in pancreatic cancer and help to develop concepts and ideas from colleagues around the country.”
In his role as the Vice Chair of the Pancreas Task Force, Cohen will regularly lead and participate in the discussion of clinical trial ideas under development and other decision-making activities of the Task Force.
The GISC's role is to implement an efficient and transparent process that will identify and promote the “best science” in clinical cancer research. The GISC is designed to facilitate the sharing of ideas among a broad range of stakeholders and provide comprehensive development of research directions and clinical trial concepts. The GISC membership is composed of investigators from the National Clinical Trials Network Groups and other NCI-funded multi-site networks; Specialized Programs of Research Excellence (SPORE); P01s; and R01s. Basic and translational scientists, community oncologists, patient advocates and extramural biostatisticians are included as well.
Cohen is certified by the American Board of Internal Medicine. He received his MD from State University of New York and completed his fellowship at Fox Chase.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427